News and Events

Keep up-to-date on the latest media coverage and events for Intragel

Intragel Expands Compassionate Use Program in Medias Klinikum to New Cancer Indications.
Medias Klinikum
Intragel Welcomes Dr. Jorge J Nieva to its Scientific Advisory Board.
DR. JORGE J NIEVA Associate Professor of Clinical Medicine, Keck School of Medicine at USC
Intragel Announces Expansion of its Head and Neck Cancer Trial to Samson Assuta Ashdod University Hospital in Israel.
Intragel Welcomes Leading Healthcare Business Executives Zeev Zehavi, MBA and Nissim Darvish MD, DSc., to its Board of Directors.
Intragel was featured in the CTech by Calcalist
Intragel Receives Approval from the Ministry of Health for its Phase II/III GMP Facility Concept at the NGT Nazareth Incubator.
Intragel announces its first head and neck cancer patient was treated with TumoCure injection, as part of its clinical trial phase 1b at Hadassah Medical Center in Israel.
IntraGel selected as a showcase presentation at the upcoming LSX World Congress.
Intragel announces world leading physician, Professor Henry Brem, M.D. has joined its Advisory Board.
PROFESSOR HENRY BRENM, MD   Cushing Professor of Neurosurgery, Johns Hopkins University, USA